The current valuation score of MiMedx Group Inc is 6.65, ranking 314 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is 17.37, which is 92.58% below the recent high of 33.45 and 2521.64% above the recent low of -420.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.